UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN C000000345
Receipt No. R000000443
Scientific Title Phase II study of neoadjuvant treatment with Exemestane for 24 weeks in postmenopausal women with hormone receptor positive Stage II or IIIA breast cancer.
Date of disclosure of the study information 2006/03/06
Last modified on 2019/03/18 09:06:46

No. Disposal Last modified on Item of update
1 Insert 2006/03/02 15:24:37
2 Update 2006/03/02 15:26:24 Date of disclosure of the study information
3 Update 2006/03/03 13:06:04 Key inclusion criteria
4 Update 2006/03/03 13:07:37 Date of disclosure of the study information
5 Update 2006/03/09 10:52:40 Last follow-up date
6 Update 2007/03/05 14:59:41
7 Update 2007/09/03 09:25:59 Organization
Organization
Division name
Division name
Address
Address

8 Update 2008/03/03 13:15:06 Recruitment status
9 Update 2008/11/26 15:09:03 Address
Address
TEL
Address
Address
TEL
Address1
Tel1
10 Update 2010/03/23 11:07:27 Last name of contact person
Last name of contact person
Address
Address
TEL
Email
Address
Institutions
11 Update 2010/03/23 11:10:06 Last follow-up date
Publication of results
Results
12 Update 2011/03/02 10:03:43 Results
13 Update 2011/04/21 13:01:36 Results
14 Update 2011/09/02 09:42:46 Post marketing survey by drug manufacture etc., specified by Japanese law.
15 Update 2013/09/02 09:05:25 TEL
Email
16 Update 2019/03/18 08:40:29 Recruitment status
Date of IRB
17 Update 2019/03/18 09:06:46 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.